Global Subcutaneous Biologics Industry 2016 Deep Market Research Report
- QYR601521
- 156 Pages
- June 2016
- Pharmaceuticals
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Subcutaneous Biologics market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Subcutaneous Biologics industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Subcutaneous Biologics
1.1 Definition and Specifications of Subcutaneous Biologics
1.1.1 Definition of Subcutaneous Biologics
1.1.2 Specifications of Subcutaneous Biologics
1.2 Classification of Subcutaneous Biologics
1.2.1 Insulin Pumps with Infusion Sets
1.2.2 Insulin Patch Pumps
1.2.3 Transdermal Patch
1.2.4 Bolus Injectors
1.3 Applications of Subcutaneous Biologics
1.4 Industry Chain Structure of Subcutaneous Biologics
1.5 Industry Overview and Major Regions Status of Subcutaneous Biologics
1.5.1 Industry Overview of Subcutaneous Biologics
1.5.2 Global Major Regions Status of Subcutaneous Biologics
1.6 Industry Policy Analysis of Subcutaneous Biologics
1.7 Industry News Analysis of Subcutaneous Biologics
2 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.1 Raw Material Suppliers and Price Analysis of Subcutaneous Biologics
2.2 Equipment Suppliers and Price Analysis of Subcutaneous Biologics
2.3 Labor Cost Analysis of Subcutaneous Biologics
2.4 Other Costs Analysis of Subcutaneous Biologics
2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.6 Manufacturing Process Analysis of Subcutaneous Biologics
3 Technical Data and Manufacturing Plants Analysis of Subcutaneous Biologics
3.1 Capacity and Commercial Production Date of Global Subcutaneous Biologics Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Subcutaneous Biologics Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Subcutaneous Biologics Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Subcutaneous Biologics Major Manufacturers in 2015
4 Capacity, Production and Revenue Analysis of Subcutaneous Biologics by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Subcutaneous Biologics by Regions 2011-2016
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Subcutaneous Biologics 2011-2016
4.3 Global Capacity, Production and Revenue of Subcutaneous Biologics by Types 2011-2016
4.4 Global Capacity, Production and Revenue of Subcutaneous Biologics by Manufacturers 2011-2016
5 Price, Cost, Gross and Gross Margin Analysis of Subcutaneous Biologics by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Subcutaneous Biologics by Regions 2011-2016
5.2 Price, Cost, Gross and Gross Margin Analysis of Subcutaneous Biologics by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Subcutaneous Biologics by Manufacturers 2011-2016
6 Consumption Volume, Consumption Value and Sale Price Analysis of Subcutaneous Biologics by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Regions 2011-2016
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Subcutaneous Biologics 2011-2016
6.3 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Types 2011-2016
6.4 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Applications 2011-2016
6.5 Sale Price of Subcutaneous Biologics by Regions 2011-2016
6.6 Sale Price of Subcutaneous Biologics by Types 2011-2016
6.7 Sale Price of Subcutaneous Biologics by Applications 2011-2016
6.8 Market Share Analysis of Subcutaneous Biologics by Different Sale Price Levels
7 Supply, Import, Export and Consumption Analysis of Subcutaneous Biologics
7.1 Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016
7.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016
8 Major Manufacturers Analysis of Subcutaneous Biologics
8.1 Abbott Laboratories
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Activa
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Adamis Pharmaceuticals Corporation
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 ADOCIA
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Advantage Health Services
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
8.6 Aguettant
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
8.6.4 Contact Information
8.7 Ajinomoto Althea Inc.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
8.7.4 Contact Information
8.8 Alnylam Pharmaceuticals
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
8.8.4 Contact Information
8.9 Amgen
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
8.9.4 Contact Information
8.10 Antares Pharma
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
8.10.4 Contact Information
8.11 Aptar Pharm
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
8.11.4 Contact Information
8.12 Aradigm Corporation
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
8.12.4 Contact Information
8.13 Arte Corporation
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
8.13.4 Contact Information
8.14 Ascendis Pharma
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
8.14.4 Contact Information
8.15 AstraZeneca
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
8.15.4 Contact Information
8.16 Bang and Olufsen
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
8.16.4 Contact Information
8.17 Battelle
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
8.17.4 Contact Information
8.18 Baxter
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
8.18.4 Contact Information
8.19 Bayer
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.2.1 Type I
8.19.2.2 Type II
8.19.2.3 Type III
8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
8.19.4 Contact Information
8.20 Becton Dickinson
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.2.1 Type I
8.20.2.2 Type II
8.20.2.3 Type III
8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
8.20.4 Contact Information
8.21 Bespak
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.2.1 Type I
8.21.2.2 Type II
8.21.2.3 Type III
8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
8.21.4 Contact Information
8.22 Biogen Idec
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.2.1 Type I
8.22.2.2 Type II
8.22.2.3 Type III
8.22.3 Capacity, Production, Price, Cost, Gross and Revenue
8.22.4 Contact Information
8.23 Bioject Medical Technologies, Inc.
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.2.1 Type I
8.23.2.2 Type II
8.23.2.3 Type III
8.23.3 Capacity, Production, Price, Cost, Gross and Revenue
8.23.4 Contact Information
8.24 Bristol-Myers Squibb Co
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.2.1 Type I
8.24.2.2 Type II
8.24.2.3 Type III
8.24.3 Capacity, Production, Price, Cost, Gross and Revenue
8.24.4 Contact Information
8.25 Calibra Medical
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.2.1 Type I
8.25.2.2 Type II
8.25.2.3 Type III
8.25.3 Capacity, Production, Price, Cost, Gross and Revenue
8.25.4 Contact Information
8.26 CeQur SA
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.2.1 Type I
8.26.2.2 Type II
8.26.2.3 Type III
8.26.3 Capacity, Production, Price, Cost, Gross and Revenue
8.26.4 Contact Information
9 Marketing Trader or Distributor Analysis of Subcutaneous Biologics
9.1 Marketing Channels Status of Subcutaneous Biologics
9.2 Traders or Distributors with Contact Information of Subcutaneous Biologics by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics
9.4 Regional Import, Export and Trade Analysis of Subcutaneous Biologics
10 Industry Chain Analysis of Subcutaneous Biologics
10.1 Upstream Major Raw Materials Suppliers Analysis of Subcutaneous Biologics
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Subcutaneous Biologics
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Subcutaneous Biologics by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Subcutaneous Biologics
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Subcutaneous Biologics
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Subcutaneous Biologics by Regions
10.3 Downstream Major Consumers Analysis of Subcutaneous Biologics
10.3.1 Major Consumers with Contact Information Analysis of Subcutaneous Biologics
10.3.2 Major Consumers with Consumption Volume Analysis of Subcutaneous Biologics by Regions
10.4 Supply Chain Relationship Analysis of Subcutaneous Biologics
11 Development Trend of Analysis of Subcutaneous Biologics
11.1 Capacity, Production and Revenue Forecast of Subcutaneous Biologics by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Subcutaneous Biologics by Regions 2016-2021
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Subcutaneous Biologics 2016-2021
11.1.3 Global Capacity, Production and Revenue of Subcutaneous Biologics by Types 2016-2021
11.2 Consumption Volume and Consumption Value Forecast of Subcutaneous Biologics by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Regions 2016-2021
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Subcutaneous Biologics 2016-2021
11.2.3 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Types 2016-2021
11.2.4 Global Consumption Volume and Consumption Value of Subcutaneous Biologics by Applications 2016-2021
11.3 Supply, Import, Export and Consumption Forecast of Subcutaneous Biologics
11.3.1 Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021
11.3.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021
12 New Project Investment Feasibility Analysis of Subcutaneous Biologics
12.1 New Project SWOT Analysis of Subcutaneous Biologics
12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics
13 Conclusion of the Global Subcutaneous Biologics Industry 2016 Market Research Report
Figure Picture of Subcutaneous Biologics
Table Product Specifications of Subcutaneous Biologics
Table Classification of Subcutaneous Biologics
Figure Global Production Market Share of Subcutaneous Biologics by Types in 2015
Figure Insulin Pumps with Infusion Sets Picture
Table Major Manufacturers of Insulin Pumps with Infusion Sets
Figure Insulin Patch Pumps Picture
Table Major Manufacturers of Insulin Patch Pumps
Figure Transdermal Patch Picture
Table Major Manufacturers of Transdermal Patch
Figure Bolus Injectors Picture
Table Major Manufacturers of Bolus Injectors
Table Applications of Subcutaneous Biologics
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Applications in 2015
Figure Industry Chain Structure of Subcutaneous Biologics
Table Global Subcutaneous Biologics Major Manufacturers
Table Global Major Regions Subcutaneous Biologics Development Status
Table Industry Policy of Subcutaneous Biologics
Table Industry News List of Subcutaneous Biologics
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2015
Figure Manufacturing Process Analysis of Subcutaneous Biologics
Table Capacity (Unit) and Commercial Production Date of Global Subcutaneous Biologics Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Subcutaneous Biologics Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Subcutaneous Biologics Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Subcutaneous Biologics Major Manufacturers in 2015
Table Global Capacity (Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Global Capacity Market Share of Subcutaneous Biologics by Regions in 2011
Figure Global Capacity Market Share of Subcutaneous Biologics by Regions in 2015
Table Global Production (Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Global Production Market Share of Subcutaneous Biologics by Regions in 2011
Figure Global Production Market Share of Subcutaneous Biologics by Regions in 2015
Table Global Revenue (M USD) of Subcutaneous Biologics by Regions 2011-2016
Figure Global Revenue Market Share of Subcutaneous Biologics by Regions in 2011
Figure Global Revenue Market Share of Subcutaneous Biologics by Regions in 2015
Figure Global Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Global Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure Global Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure USA Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure USA Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure USA Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure EU Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure EU Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure EU Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure China Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure China Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure China Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Japan Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Japan Capacity Utilization Rate of Subcutaneous Biologics 2011-2016
Figure Japan Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Table Global Capacity (Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Global Capacity Market Share of Subcutaneous Biologics by Types in 2011
Figure Global Capacity Market Share of Subcutaneous Biologics by Types in 2015
Table Global Production (Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Global Production Market Share of Subcutaneous Biologics by Types in 2011
Figure Global Production Market Share of Subcutaneous Biologics by Types in 2015
Table Global Revenue (M USD) of Subcutaneous Biologics by Types 2011-2016
Figure Global Revenue Market Share of Subcutaneous Biologics by Types in 2011
Figure Global Revenue Market Share of Subcutaneous Biologics by Types in 2015
Table Global and Major Manufacturers Capacity (Unit) of Subcutaneous Biologics 2011-2016
Table Global Capacity Market Share of Subcutaneous Biologics Major Manufacturers 2011-2016
Figure Global Capacity Market Share of Subcutaneous Biologics Major Manufacturers in 2011
Figure Global Capacity Market Share of Subcutaneous Biologics Major Manufacturers in 2015
Table Global and Major Manufacturers Production (Unit) of Subcutaneous Biologics 2011-2016
Table Global Production Market Share of Subcutaneous Biologics Major Manufacturers 2011-2016
Figure Global Production Market Share of Subcutaneous Biologics Major Manufacturers in 2011
Figure Global Production Market Share of Subcutaneous Biologics Major Manufacturers in 2015
Table Global and Major Manufacturers Revenue (M USD) of Subcutaneous Biologics 2011-2016
Table Global Revenue Market Share of Subcutaneous Biologics Major Manufacturers 2011-2016
Figure Global Revenue Market Share of Subcutaneous Biologics Major Manufacturers in 2011
Figure Global Revenue Market Share of Subcutaneous Biologics Major Manufacturers in 2015
Table Price (USD/Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Price (USD/Unit) of Subcutaneous Biologics by Regions in 2015
Table Cost (USD/Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Cost (USD/Unit) of Subcutaneous Biologics by Regions in 2015
Table Gross (USD/Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Gross (USD/Unit) of Subcutaneous Biologics by Regions in 2015
Table Gross Margin of Subcutaneous Biologics by Regions 2011-2016
Figure Gross Margin of Subcutaneous Biologics by Regions in 2015
Table Price (USD/Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Price (USD/Unit) of Subcutaneous Biologics by Types in 2015
Table Cost (USD/Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Cost (USD/Unit) of Subcutaneous Biologics by Types in 2015
Table Gross (USD/Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Gross (USD/Unit) of Subcutaneous Biologics by Types in 2015
Table Gross Margin of Subcutaneous Biologics by Types 2011-2016
Figure Gross Margin of Subcutaneous Biologics by Types in 2015
Table Price (USD/Unit) of Subcutaneous Biologics by Manufacturers 2011-2016
Figure Price (USD/Unit) of Subcutaneous Biologics by Manufacturers in 2015
Table Cost (USD/Unit) of Subcutaneous Biologics by Manufacturers 2011-2016
Figure Cost (USD/Unit) of Subcutaneous Biologics by Manufacturers in 2015
Table Gross (USD/Unit) of Subcutaneous Biologics by Manufacturers 2011-2016
Figure Gross (USD/Unit) of Subcutaneous Biologics by Manufacturers in 2015
Table Gross Margin of Subcutaneous Biologics by Manufacturers 2011-2016
Figure Gross Margin of Subcutaneous Biologics by Manufacturers in 2015
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2011
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2015
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Regions 2011-2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Regions in 2011
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Regions in 2015
Figure Global Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Global Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure USA Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure USA Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure EU Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure EU Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure China Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure China Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Japan Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016
Figure Japan Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Types in 2011
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Types in 2015
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Types 2011-2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Types in 2011
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Types in 2015
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Applications 2011-2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Applications in 2011
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Applications in 2015
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Applications 2011-2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Applications in 2011
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Applications in 2015
Table Sale Price (USD/Unit) of Subcutaneous Biologics by Regions 2011-2016
Figure Sale Price (USD/Unit) of Subcutaneous Biologics by Regions in 2015
Table Sale Price (USD/Unit) of Subcutaneous Biologics by Types 2011-2016
Figure Sale Price (USD/Unit) of Subcutaneous Biologics by Types in 2015
Table Sale Price (USD/Unit) of Subcutaneous Biologics by Applications 2011-2016
Figure Sale Price (USD/Unit) of Subcutaneous Biologics by Applications in 2015
Table Market Share of Subcutaneous Biologics by Different Sale Price Levels
Table Global Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table USA Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table EU Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table China Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table Japan Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)
Table Global Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table USA Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table USA Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table EU Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table EU Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table China Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table China Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table Japan Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016
Table Japan Supply, Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)
Table Abbott Laboratories Information List
Figure Subcutaneous Biologics Picture and Specifications of Abbott Laboratories
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Abbott Laboratories 2011-2016
Table Activa Information List
Figure Subcutaneous Biologics Picture and Specifications of Activa
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Activa 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Activa 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Activa 2011-2016
Table Adamis Pharmaceuticals Corporation Information List
Figure Subcutaneous Biologics Picture and Specifications of Adamis Pharmaceuticals Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Adamis Pharmaceuticals Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Adamis Pharmaceuticals Corporation 2011-2016
Table ADOCIA Information List
Figure Subcutaneous Biologics Picture and Specifications of ADOCIA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ADOCIA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of ADOCIA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of ADOCIA 2011-2016
Table Advantage Health Services Information List
Figure Subcutaneous Biologics Picture and Specifications of Advantage Health Services
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Advantage Health Services 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Advantage Health Services 2011-2016
Table Aguettant Information List
Figure Subcutaneous Biologics Picture and Specifications of Aguettant
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aguettant 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aguettant 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Aguettant 2011-2016
Table Ajinomoto Althea Inc. Information List
Figure Subcutaneous Biologics Picture and Specifications of Ajinomoto Althea Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ajinomoto Althea Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Ajinomoto Althea Inc. 2011-2016
Table Alnylam Pharmaceuticals Information List
Figure Subcutaneous Biologics Picture and Specifications of Alnylam Pharmaceuticals
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Alnylam Pharmaceuticals 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Alnylam Pharmaceuticals 2011-2016
Table Amgen Information List
Figure Subcutaneous Biologics Picture and Specifications of Amgen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Amgen 2011-2016
Table Antares Pharma Information List
Figure Subcutaneous Biologics Picture and Specifications of Antares Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Antares Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Antares Pharma 2011-2016
Table Aptar Pharm Information List
Figure Subcutaneous Biologics Picture and Specifications of Aptar Pharm
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aptar Pharm 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Aptar Pharm 2011-2016
Table Aradigm Corporation Information List
Figure Subcutaneous Biologics Picture and Specifications of Aradigm Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aradigm Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Aradigm Corporation 2011-2016
Table Arte Corporation Information List
Figure Subcutaneous Biologics Picture and Specifications of Arte Corporation
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Arte Corporation 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Arte Corporation 2011-2016
Table Ascendis Pharma Information List
Figure Subcutaneous Biologics Picture and Specifications of Ascendis Pharma
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ascendis Pharma 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Ascendis Pharma 2011-2016
Table AstraZeneca Information List
Figure Subcutaneous Biologics Picture and Specifications of AstraZeneca
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of AstraZeneca 2011-2016
Table Bang and Olufsen Information List
Figure Subcutaneous Biologics Picture and Specifications of Bang and Olufsen
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bang and Olufsen 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Bang and Olufsen 2011-2016
Table Battelle Information List
Figure Subcutaneous Biologics Picture and Specifications of Battelle
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Battelle 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Battelle 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Battelle 2011-2016
Table Baxter Information List
Figure Subcutaneous Biologics Picture and Specifications of Baxter
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Baxter 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Baxter 2011-2016
Table Bayer Information List
Figure Subcutaneous Biologics Picture and Specifications of Bayer
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Bayer 2011-2016
Table Becton Dickinson Information List
Figure Subcutaneous Biologics Picture and Specifications of Becton Dickinson
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Becton Dickinson 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Becton Dickinson 2011-2016
Table Bespak Information List
Figure Subcutaneous Biologics Picture and Specifications of Bespak
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bespak 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bespak 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Bespak 2011-2016
Table Biogen Idec Information List
Figure Subcutaneous Biologics Picture and Specifications of Biogen Idec
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biogen Idec 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Biogen Idec 2011-2016
Table Bioject Medical Technologies, Inc. Information List
Figure Subcutaneous Biologics Picture and Specifications of Bioject Medical Technologies, Inc.
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bioject Medical Technologies, Inc. 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Bioject Medical Technologies, Inc. 2011-2016
Table Bristol-Myers Squibb Co Information List
Figure Subcutaneous Biologics Picture and Specifications of Bristol-Myers Squibb Co
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bristol-Myers Squibb Co 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Bristol-Myers Squibb Co 2011-2016
Table Calibra Medical Information List
Figure Subcutaneous Biologics Picture and Specifications of Calibra Medical
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Calibra Medical 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of Calibra Medical 2011-2016
Table CeQur SA Information List
Figure Subcutaneous Biologics Picture and Specifications of CeQur SA
Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CeQur SA 2011-2016
Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of CeQur SA 2011-2016
Figure Subcutaneous Biologics Production (Unit) and Global Market Share of CeQur SA 2011-2016
Figure Marketing Channels of Subcutaneous Biologics
Table Traders or Distributors with Contact Information of Subcutaneous Biologics by Regions
Table Ex-work Price, Channel Price and End Buyer Price of Subcutaneous Biologics (USD/Unit)
Table Regional Import, Export, and Trade of Subcutaneous Biologics (Unit)
Table Flow of International Trade in 2015
Table Major Raw Materials Suppliers with Contact Information of Subcutaneous Biologics
Table Major Raw Materials Suppliers with Supply Volume of Subcutaneous Biologics by Regions
Table Major Equipment Suppliers with Contact Information of Subcutaneous Biologics
Table Major Equipment Suppliers with Product Pictures of Subcutaneous Biologics by Regions
Table Major Consumers with Contact Information of Subcutaneous Biologics
Table Major Consumers with Consumption Volume of Subcutaneous Biologics by Regions
Figure Supply Chain Relationship Analysis of Subcutaneous Biologics
Table Global Capacity (Unit) of Subcutaneous Biologics by Regions 2016-2021
Figure Global Capacity Market Share of Subcutaneous Biologics by Regions in 2016
Figure Global Capacity Market Share of Subcutaneous Biologics by Regions in 2021
Table Global Production (Unit) of Subcutaneous Biologics by Regions 2016-2021
Figure Global Production Market Share of Subcutaneous Biologics by Regions in 2016
Figure Global Production Market Share of Subcutaneous Biologics by Regions in 2021
Table Global Revenue (M USD) of Subcutaneous Biologics by Regions 2016-2021
Figure Global Revenue Market Share of Subcutaneous Biologics by Regions in 2016
Figure Global Revenue Market Share of Subcutaneous Biologics by Regions in 2021
Figure Global Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Global Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Figure Global Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure USA Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure USA Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Figure USA Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure EU Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure EU Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Figure EU Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure China Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure China Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Figure China Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Japan Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Japan Capacity Utilization Rate of Subcutaneous Biologics 2016-2021
Figure Japan Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Table Global Capacity (Unit) of Subcutaneous Biologics by Types 2016-2021
Figure Global Capacity Market Share of Subcutaneous Biologics by Types in 2016
Figure Global Capacity Market Share of Subcutaneous Biologics by Types in 2021
Table Global Production (Unit) of Subcutaneous Biologics by Types 2016-2021
Figure Global Production Market Share of Subcutaneous Biologics by Types in 2016
Figure Global Production Market Share of Subcutaneous Biologics by Types in 2021
Table Global Revenue (M USD) of Subcutaneous Biologics by Types 2016-2021
Figure Global Revenue Market Share of Subcutaneous Biologics by Types in 2016
Figure Global Revenue Market Share of Subcutaneous Biologics by Types in 2021
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Regions 2016-2021
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2021
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Regions 2016-2021
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Regions in 2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Regions in 2021
Figure Global Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Global Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure USA Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure USA Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure EU Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure EU Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure China Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure China Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Japan Consumption Volume (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021
Figure Japan Consumption Value (M USD) and Growth Rate of Subcutaneous Biologics 2016-2021
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Types 2016-2021
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Types in 2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Types in 2021
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Types 2016-2021
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Types in 2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Types in 2021
Table Global Consumption Volume (Unit) of Subcutaneous Biologics by Applications 2016-2021
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Applications in 2016
Figure Global Consumption Volume Market Share of Subcutaneous Biologics by Applications in 2021
Table Global Consumption Value (M USD) of Subcutaneous Biologics by Applications 2016-2021
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Applications in 2016
Figure Global Consumption Value Market Share of Subcutaneous Biologics by Applications in 2021
Table Global Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021 (Unit)
Table USA Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021 (Unit)
Table EU Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021 (Unit)
Table China Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021 (Unit)
Table Japan Supply, Consumption and Gap of Subcutaneous Biologics 2016-2021 (Unit)
Table Global Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table USA Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table USA Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)
Table EU Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table EU Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)
Table China Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table China Supply, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)
Table Japan Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021
Table
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
